Alexi Bueno Soler

Placeholder Person Graphic
Alexi Bueno Soler is a Chemical Engineer who has worked in the R&D BioProcess Development Department at the Center of Molecular Immunology in Havana since 2010. Alexi focuses on the development of fermentation processes at a scale of 2 and 30 liters, and the quantification of monoclonal antibodies by ELISA.

Related Articles

Figure 4: SDS-PAGE under nonreduced conditions of the fi nal purified SP Sepharose Fast Flow.
Technical
Effects of Tank-Agitated Fermentation on Therapeutic mAb Quality

Regulatory authorities have approved the use of recombinant monoclonal antibodies (mAbs) to treat infectious diseases1  and chronic conditions such as cancer

  • 1Sparrow, E., M. Friede, M. Sheikh, and S. Torvaldsen. “Therapeutic Antibodies for Infectious Diseases.” Bulletin of the World Health Organization 95, no. 3 (2017):235–237. doi:10.2471/BLT.16.178061